<SEC-DOCUMENT>0001213900-18-004078-index.html : 20180405
<SEC-HEADER>0001213900-18-004078.hdr.sgml : 20180405
<ACCEPTANCE-DATETIME>20180405082002
ACCESSION NUMBER:		0001213900-18-004078
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20180326
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180405
DATE AS OF CHANGE:		20180405

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Immudyne, Inc.
		CENTRAL INDEX KEY:			0000948320
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				760238453
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-55857
		FILM NUMBER:		18739355

	BUSINESS ADDRESS:	
		STREET 1:		1460 BROADWAY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
		BUSINESS PHONE:		914-244-1777

	MAIL ADDRESS:	
		STREET 1:		1460 BROADWAY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IMMUDYNE INC
		DATE OF NAME CHANGE:	19950720
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k032618b_immudyneinc.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: f8k032618b_immudyneinc.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>f8k032618bex10-1_immudyne.htm
<DESCRIPTION>PURPUREX LICENSE AGREEMENT BY AND BETWEEN IMMUDYNE, PR, LLC AND M.ALPHABET, LLC, DATED MARCH 26, 2018
<TEXT>
Document 2 - file: f8k032618bex10-1_immudyne.htm

</DOCUMENT>
</SEC-DOCUMENT>